WenXue Wu
4PUBLICATIONS
10CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|May 14, 2025
Discovery and Characterization of PVTX-321 as a Potent and Orally Bioavailable Estrogen Receptor Degrader for ER+/HER2- Breast Cancer.Guozhang Xu, Courtney G Havens, Qiaolin Deng
|Apr 08, 2025
Correction to "Discovery of ERD-1233 as a Potent and Orally Efficacious Estrogen Receptor PROTAC Degrader for the Treatment of ER+ Human Breast Cancer".Ranjan Kumar Acharyya, Rohan Kalyan Rej, Biao Hu
|Nov 25, 2024
Discovery of ERD-12310A as an Exceptionally Potent and Orally Efficacious PROTAC Degrader of Estrogen Receptor α (ERα).Rohan Kalyan Rej, Biao Hu, Zhixiang Chen
|Nov 01, 2024
Discovery of ERD-1233 as a Potent and Orally Efficacious Estrogen Receptor PROTAC Degrader for the Treatment of ER+ Human Breast Cancer.Ranjan Kumar Acharyya, Rohan Kalyan Rej, Biao Hu
Pageof 1
Frequent Collaborators
4 joint publications
Ranjan Kumar Acharyya
4 joint publications
Rohan Kalyan Rej
4 joint publications
E Scott Priestley
4 joint publications
Shaomeng Wang
3 joint publications
Biao Hu
3 joint publications
Zhixiang Chen
3 joint publications
Duxin Sun
2 joint publications
Jelena Tošović
1 joint publications
John A Katzenellenbogen
1 joint publications
Xuqing Zhang
